HVDs in the EU :-(( [Design Issues]

posted by drks  – 2007-07-07 17:53 (6930 d 06:28 ago) – Posting: # 870
Views: 7,240

Dear Helmut,

❝ Where did you get your CV% from? Even for lansoprazole >50% is rather high!

❝ There are studies published with a CV% of 30-40 for Cmax. :-D


I would agree with Shankar in this regard. There are studies with such high variability (70-80%) observed with lansoprazole. We have observed similar variability for lansoprazole, particularly with fed studies. In fact, for various studies submitted to MHRA, the confidence interval has been widened on the basis of high variability. One can find different approvals with studies showing such high variability at the MHRA site upon searching for lansoprazole.

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,572 registered users;
354 visitors (0 registered, 354 guests [including 26 identified bots]).
Forum time: 00:21 CEST (Europe/Vienna)

Don’t compromise yourself.
You are all you’ve got.    Janis Joplin

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5